JBIO
JBIO
NASDAQ · Biotechnology

Jade Biosciences Inc

$14.00
-0.08 (-0.57%)
As of Mar 22, 10:17 PM ET ·
Financial Highlights (FY 2025)
Revenue
85.08M
Net Income
21.83M
Gross Margin
34.4%
Profit Margin
25.7%
Rev Growth
+15.3%
D/E Ratio
0.18
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 34.4% 34.4% 34.4%
Operating Margin 26.1% 24.7% 25.6%
Profit Margin 25.7% 24.8% 21.6%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 85.08M 76.59M 82.32M
Gross Profit 29.30M 26.38M 28.35M
Operating Income 22.23M 18.89M 21.11M
Net Income 21.83M 19.00M 17.76M
Gross Margin 34.4% 34.4% 34.4%
Operating Margin 26.1% 24.7% 25.6%
Profit Margin 25.7% 24.8% 21.6%
Rev Growth +15.3% +2.7% +8.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 76.69M 69.48M 73.29M
Total Equity 434.50M 430.53M 489.70M
D/E Ratio 0.18 0.16 0.15
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 33.39M 28.41M 32.89M
Free Cash Flow 16.91M 11.51M 18.65M